Skip to content

Columbia Ventures Corporation

Creating, Discovering and Enhancing Capital Values

Team
Philosophy
Portfolio
News
Contact

Vancouver-based AbSci wins $125 million from new investors

Read now on columbian.com • March 23, 2021

Share this:

Twitter
Facebook

Like this:

Like Loading...

Author Columbia VenturesPosted on March 23, 2021Categories AbSci, BIOMEDICAL

Post navigation

Previous Previous post: AbSci announces completion of $125 million crossover financing to advance AI-powered synthetic biology drug creation platform

Next Next post: Make Paper from Straw

Recent News

2degrees and Lynk Global will bring satellite-to-phone coverage to New Zealand May 18, 2023
Four years after CES, Breadbot’s robotic breadmaker is dishing out loaves at grocery stores May 2, 2023
RealWear unveils next generation assisted reality headset for modern frontline professional with all April 18, 2023

Copyright © Columbia Ventures Corporation. All Rights Reserved.

News by Industry/Company

News by Industry/Company

Search Site

Search for:

Team
Philosophy
Portfolio
News
Contact

Columbia Ventures Corporation

Follow Following
- Columbia Ventures Corporation
- Already have a WordPress.com account? Log in now.

%d bloggers like this: